Share: Facebook Twitter LinkedIn
Activity Provided By:

AKH Inc. Advancing Knowledge in Healthcare

New and Emerging Therapeutic Options for the Prophylaxis, Empirical Treatment, Pre-Emptive and Targeted Treatment of Invasive Fungal Infections (IFIs)

Access Activity

Overview / Abstract:

Target audience
The enduring activity is intended for health care professionals, particularly physicians, clinical microbiologists, researchers, nurse, nurse practitioners and pharmacists, specializing in prevention and management of fungal infections.

Learning objectives
Upon completion of the educational activity, participants should be able to:
-Differentiate new and emerging therapeutic options for the prophylaxis, empirical treatment, pre-emptive and targeted treatment of invasive fungal infections (IFIs) including invasive aspergillosis and invasive candidiasis.

Method of Participation
In order to receive credit, participants should read the entire monograph, complete and submit an evaluation and score at least 70% on the self-assessment test. AKH Inc. allows for one (1) re-test at no additional charge; additional re-tests must be purchased again at the full cost. Statements of Credit will be available upon successful completion of the self-assessment test. If you have questions about this CME/CE activity, please contact AKH Inc. at service@akhcme.com.

Disclosure Declaration
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Products
This educational activity does not include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
AKH Inc.ís activities are designed solely to provide healthcare professionals with information to assist in their practice and professional development. The activities are researched thoroughly, utilizing current literature and including practical experiences. AKHís activities are not to be considered a diagnostic tool to replace professional advice or treatment. The activities serve as a general guide to the healthcare professional, and therefore, they cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH educational activities do not endorse commercial products. The author(s) and the publisher specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the activities. AKH further disclaims any responsibility for undetected errors, or from the readerís misunderstanding of the activity.

Copyright © 2014 AKH Inc., Advancing Knowledge in Healthcare No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.

Expiration

Dec 31, 2017

Discipline(s)

Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME, Physician Assistant CME

Format

Monograph, Online

Credits / Hours

0.50

Accreditation

Credit available

Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and the Mycoses Study Group Education & Research Consortium (MSGERC). AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Pharmacy
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for .5 contact hour(s) (0.05 CEUs). UAN 0077-9999-15-004-H04-P. Initial Release Date: January 1, 2015.

Nursing
AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded .5 Contact Hours.

Nurse Practitioners
AKH, Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
This program is accredited for .5 contact hour(s) which includes 0.5 hour(s) of pharmacology. Program ID #21449.

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standard

Presenters / Authors / Faculty

Faculty & credentials

Keith M. Olsen, PharmD, FCCP, FCCM
Keith M. Olsen, PharmD, FCCP, FCCM is a professor of Pharmacy and Chair, Department of Pharmacy Practice at the University of Nebraska Medical Center and a Critical Care Specialist for the Nebraska Health System, both in Omaha. He earned his PharmD and completed a residency at the University of Nebraska Medical Center.
He is recognized as a fellow of the American College of Clinical Pharmacy and the American College of Critical Care Medicine. Twice graduating doctor of pharmacy classes has recognized him as the teacher of the year. He has published over 275 peer-reviewed publications, abstracts, and book chapters in the areas of critical care pharmacotherapy, and infectious diseases. He was elected as a Regent for the American College of Critical Care Medicine in 2010 and re-elected in 2013 and was elected to the Board of Trustees Research Institute for the American College of Clinical Pharmacy-2012.
Dr Olsen discloses no financial relationships with pharmaceutical or medical product manufacturers.

Activity Specialities / Related Topics

Infectious Disease, Preventive Care

Sponsors / Supporters / Grant Providers

COMMERCIAL SUPPORT

This activity is supported by an educational grant from Astellas, Merck, IMMY, MiraVista Diagnostics & MiraBella Technologies, T2 Biosystems, Inc., Viracor-IBT Laboratories.

Keywords / Search Terms

AKH Inc. Advancing Knowledge in Healthcare therapeutic options, prophylaxis, empirical treatment, pre-emptive and targeted treatment of invasive fungal infections (IFIs); invasive aspergillosis; invasive candidiasis Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map